№ files_lp_4_process_3_131993
Guidance document detailing regulatory restrictions on claiming MBS services when non-haematopoietic stem cells are harvested, processed, or injected, outlining implications for providers and patients.
Year: 2018
Jurisdiction: Australia
Topic: Health policy, medical billing
Document type: Guidance notice
Issuing body: Department of Health
Author: Medical Services Advisory Committee Executive
Target audience: Healthcare providers
Effective date: 1 November 2018
Last updated: 11 October 2018
Regulatory reference: Health Insurance (General Medical Services Table) Regulations; Health Insurance (Pathology Services Table) Regulations; Health Insurance (Diagnostic Imaging Services Table) Regulations
Related legislation: Therapeutic Goods Administration regulations on human cells and tissues
Scope: Non-haematopoietic stem cell treatments
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.